Neutropenia Prediction Based on First-Cycle Blood Counts Using a FOS-3NN Classifier

Table 1

(a) shows characteristics of the patient population. (b) shows treatment characteristics.

(a)

Group	Median age at first chemotherapy treatment
Training set	46.79
Testing set	44.8
Validation set	56.19
Entire population	46.34
Group	BMI at first chemotherapy treatment
Training set	24.29
Testing set	25.7
Validation set	25.86
Entire population	25.71

(b)

	Training set	Testing set	Validation set	Entire patient population
	𝑁=14	𝑁=14	𝑁=7
Radiation
Concurrent	9 (64.3%)	0 (0%)	0 (0%)	9 (25.7%)
Chemotherapy
CEF	0 (0%)	12 (85.7%)	2 (28.6%)	14 (40%)
CAF	0 (0%)	1 (7.1%)	5 (71.4%)	6 (17.1%)
CMF	14 (100%)	1 (7.1%)	0 (0%)	15 (42.9%)
Risk
High	7 (50%)	7 (50%)	4 (57.1%)	18 (51.4%)
low	7 (50%)	7 (50%)	3 (42.9%)	17 (48.6%)

*Note that percentages may not add to 100% due to rounding.